A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as amyloid plaques from the brain. However, few countries have approved ...

Among the list of drugs in development for Alzheimer's compiled by Phrma, there is an interesting proposal, the protease inhibitor atzuginstat, which by targeting the periodontal pathogen ...

Now, a board-certified anesthesiologist in Los Angeles is revealing five daily medications that may also increase your likelihood of developing dementia, a group of brain disorders that affects ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Lilly’s solanezumab famously failed to produce significant results in early stage Alzheimer’s late last year, the latest in a long list of drugs that have come up short in trials. George ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that ... stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

The federal Food & Drug Administration has approved two new Alzheimer’s medications that can offer people more time to live normally, but accessing them in Florida is complicated. Hold-ups ...

Prof Sir John Hardy is chairman of molecular biology of neurological disease at the UCL Institute of Neurology - Paul Grover for the Telegraph Alzheimer’s drugs should be prescribed like statins ...